Lv2
110 积分 2025-11-10 加入
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study
2个月前
已完结
Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk–Benefit Analysis
2个月前
已完结
Age of Diagnosis of Breast Cancer in China: Almost 10 Years Earlier than in the United States and the European Union
3个月前
已关闭
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
3个月前
已完结
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
3个月前
已完结
Breast Cancer Treatment
3个月前
已完结
Clinicopathologic and immunohistochemical study of breast angiosarcoma
6个月前
已完结
Radiogenic angiosarcoma of the breast: case report and systematic review of the literature
6个月前
已完结
Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression
6个月前
已完结
[Melanoma simulating malignant soft tissue tumour]
6个月前
已关闭
皖公网安备34019202002308
